Niagen Bioscience, Inc.
NASDAQNAGE put/call ratio collapses to 0.25, hitting four standard deviations below the 20-day mean of 0.58—the lowest level in 52 weeks, signaling aggressive call buying and bullish sentiment as the stock rallies ahead of earnings May 6.
Snapshot as of 6 May 2026
No long-form analysis yet for NAGE. Pulse alerts and the live data picture are available on ORTEX.
Open NAGE on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NAGE — free to start on ORTEX.
Sign up for free →Open NAGE on ORTEX